NCT02985879
Progressive Supranuclear Palsy
A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP)
The purpose of this study was to assess efficacy, safety, tolerability, and pharmacokinetics of ABBV-8E12 in participants with progressive supranuclear palsy (PSP).
The purpose of this study is to assess efficacy, safety, tolerability, and pharmacokinetics of an active drug in subjects with progressive supranuclear palsy (PSP).
Recruitment Status
Terminated
